Skip to main content
. 2016 Dec 21;9:9–17. doi: 10.2147/CEOR.S108730

Figure 2.

Figure 2

Persistence with biologic therapy: adalimumab, etanercept and infliximab.

Notes: First year: Eta vs. Ada p=0.69; Eta vs. Inf p=0.007; Ada vs. Inf p=0.32. Second year: Eta vs. Ada p<0.001; Eta vs. Inf p=0.002; Ada vs. Inf p=0.54. Third year: Eta vs. Ada p=0.008; Eta vs. Inf p=0.014; Ada vs. Inf p=0.88. Fourth year: Eta vs. Ada p=0.002; Eta vs. Inf p=0.031; Ada vs. Inf p=0.62.

Abbreviations: Eta, etanercept; Ada, adalimumab; Inf, infliximab.